Jane Street’s CorMedix CRMD Stock Holding History

Jane Street’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Sell	169,000 -49,400	-23%	-$390K	﹤0.01%	5940
2026 Q1	$1.48M	Buy	218,400 +139,800	+178%	+$1.03M	﹤0.01%	5672
2025 Q4	$914K	Sell	78,600 -48,000	-38%	-$531K	﹤0.01%	6308
2025 Q3	$1.47M	Buy	126,600 +27,500	+28%	+$332K	﹤0.01%	5504
2025 Q2	$1.22M	Buy	99,100 +7,900	+9%	+$87.2K	﹤0.01%	5250
2025 Q1	$562K	Buy	91,200 +21,600	+31%	+$224K	﹤0.01%	6649
2024 Q4	$564K	Buy	+69,600	New	+$695K	﹤0.01%	6543
2023 Q3	–	Sell	-11,000	Closed	-$43.6K	–	8720
2023 Q2	$43.6K	Buy	+11,000	New	+$54.4K	﹤0.01%	8239
2021 Q3	–	Sell	-17,500	Closed	-$120K	–	10010
2021 Q2	$120K	Sell	17,500 -29,800	-63%	-$237K	﹤0.01%	9179
2021 Q1	$473K	Buy	+47,300	New	+$498K	﹤0.01%	6896

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jane Street's CRMD Position: Q2 2026 in Review

Jane Street opened a new position in CorMedix (CRMD) in Q2 2026: 145,146 shares worth $1.14M. The stake represents ﹤0.01% of the portfolio and ranks #6254 among its holdings. This is a return to the name: Jane Street previously reported a position in CRMD as recently as Q4 2025.

Jane Street first reported a position in CRMD in Q2 2015 and has held it in 15 quarters since. The position peaked at $3.52M in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Jane Street held 145,146 shares of CorMedix worth $1.14M as of Q2 2026.
CorMedix was a new Jane Street position in Q2 2026.
CorMedix made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6254 holding.
Jane Street first reported a position in CorMedix in Q2 2015 and has held it in 15 quarters since.
Jane Street's CorMedix position peaked at $3.52M in Q2 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.